Jubilant Pharmova announced that one of its subsidiaries received Abbreviated New Drug Application (ANDA) final approval for Doxepin Hydrochloride Capsules, the generic version of Sinequan, which is used for the treatment of anxiety, depression, and other symptoms of psychoneurosis.
